Layton, UT, United States of America

Michael K Black

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Fresenius Medical Care Holdings, Inc.. Active years: 2016-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael K Black: Innovator in Hemodialysis Technology

Introduction

Michael K Black is a notable inventor based in Layton, UT (US). He has made significant contributions to the field of hemodialysis through his innovative patents. With a total of 2 patents, Black's work focuses on improving patient care and monitoring during hemodialysis treatments.

Latest Patents

One of his latest patents is titled "Wireless monitoring of hemodialysis treatment data in real-time via a blood monitor network." This invention involves a hemodialysis patient data acquisition and management system that operates on a host computer. The system receives information from non-invasive, optical blood monitors associated with a hemodialysis system. During treatment, a sensor assembly monitors the patient's blood, and a controller generates data that includes an identification code for the patient and non-invasively determined blood data, such as initial Hgb, HCT, and SAT values. The host computer communicates with the optical blood monitors via a wireless network, allowing for efficient data management.

Another significant patent by Black is the "Hemodialysis patient data acquisition, management and analysis system." Similar to his previous work, this system resides on a host computer that collects data from optical blood monitors. It includes a patient database containing historical session commencement data for multiple patients. The system also features screen displays for individual patient data, such as Hgb trends, and provides a predictive algorithm for the patient's Hgb at the next scheduled treatment session. Additionally, it includes software that recommends a dose of anemia management drugs for patients.

Career Highlights

Michael K Black is associated with Fresenius Medical Care Holdings, Inc., a leading company in the healthcare sector. His work has been instrumental in advancing technologies that enhance patient monitoring and treatment efficiency in hemodialysis.

Collaborations

Throughout his career, Black has collaborated with notable colleagues, including Louis Leegrande Barrett and David W Peterson. Their combined expertise has contributed to the development of innovative solutions in the field of hemodialysis.

Conclusion

Michael K Black's contributions to hemodialysis technology through his patents demonstrate his commitment to improving patient care. His innovative systems are paving the way for more effective monitoring and management of hemodialysis treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…